Analysis of human hepatocellular carcinoma (HCC) tissues in relation to patient overall survival showed poorer prognosis for those having tumours expressing MORs and vimentin or MOR with concomitant absence of E-cadherins. This evidence concerns the gene CDH1 and neoplasm.